Download PDF
1 / Pages

Other users also viewed these articles

Insulin resistance and Metabolic dysfunction-associated steatotic liver disease (MASLD): Pathways of action of hypoglycemic agents Andrea del Carmen Maldonado-Rojas; Julia María Zuarth-Vázquez; Misael Uribe; Varenka J Barbero-Becerra;
Ann Hepatol. 2024;29:
O-18 DIFFERENCES IN BODY COMPOSITION OF MAFLD PATIENTS ACCORDING TO BODY MASS INDEX AND METABOLIC PROFILE Eva Juárez; Iván López; Karen Bernal; Alain Velázquez; Andrea Maldonado; Martha Helena Ramos; Misael Uribe; Graciela Castro;
Ann Hepatol. 2024;29 Supl 1:
Anti-gp210-positive primary biliary cholangitis: The dilemma of clinical treatment and emerging mechanisms Xiaoyi Wang; Zhen Yang; Ying Ran; Long Li; Bangmao Wang; Lu Zhou;
Ann Hepatol. 2023;28: